Indications and uses
Temporarily relieves minor pain
Temporarily relieves minor pain
Adults and children over 12 years : Clean and dry affected area. Remove film from patch (see illustration). Apply sticky side of patch to affected area. Use one patch for up to 12 hours. Discard patch after single use Children 12 years of age or younger : Consult a physician.
Lidocaine 4.0%
Topical anesthetic
Temporarily relieves minor pain
For external use only
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Adults and children over 12 years: Clean and dry affected area. Remove film from patch (see illustration). Apply sticky side of patch to affected area. Use one patch for up to 12 hours. Discard patch after single use
Children 12 years of age or younger: Consult a physician.
Store in a clean, dry place outside of direct sunlight. Protect from excessive moisture.
aluminum glycinate, glycerin, kaolin, methylparaben, polyacrylic acid, polysorbate 80, propylene glycol, propylparaben, PVP, sodium polyacrylate, tartaric acid, titanium dioxide, water
CALL 1-888-287-1915
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 79903-106-06 | 2024-03-15 | C162847 | 48780-1 | 1030e365-383f-111a-e063-dadaa90a10e2 | EQUATE PAIN RELIEVING PATCH - LIDOCAINE 4% |
| 79903-106-06 | 2024-03-15 | C162847 | 48780-1 | 1030e365-383f-111a-e063-dadaa90a10e2 | EQUATE PAIN RELIEVING PATCH - LIDOCAINE 4% |
| 79903-106-06 | 2024-01-30 | C162847 | 48780-1 | 1030e365-383f-111a-e063-dadaa90a10e2 | EQUATE PAIN RELIEVING PATCH - LIDOCAINE 4% |
| 79903-106-06 | 2024-01-30 | C162847 | 48780-1 | 1030e365-383f-111a-e063-dadaa90a10e2 | EQUATE PAIN RELIEVING PATCH - LIDOCAINE 4% |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 79903-106-06 | EQUATE PAIN RELIEVING PATCHES | 6 in 1 BOX | PATCH | 6 | 4 | |
| 79903-106-06 | EQUATE PAIN RELIEVING PATCHES | 1 in 1 POUCH | PATCH | 1 | 4 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 79903-106-06 | EA - Each | 79903-106 | 9779173b-cce6-4e1e-b295-e8904b68382a | 1 | 2023-09-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 79903-106 | 79903-106-06 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| POVIDONE | FZ989GH94E | IACT |
| LIDOCAINE | 98PI200987 | ACTIB |
| KAOLIN | 24H4NWX5CO | IACT |
| TARTARIC ACID | W4888I119H | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| WATER | 059QF0KO0R | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| SODIUM POLYACRYLATE (8000 MW) | 285CYO341L | IACT |
| POLYACRYLIC ACID (250000 MW) | 9G2MAD7J6W | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| DIHYDROXYALUMINUM AMINOACETATE | DO250MG0W6 | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| GELATIN | 2G86QN327L | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 3 | 2024-03-15 | full-release | 2026-06-01 00:09:54 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EQUATE PAIN RELIEVING PATCHES | LIDOCAINE 4% | WALMART, INC | d91cc701-5e0a-d6c2-e053-2a95a90a9e75 | 2025-10-08 | Warnings | 79903-106-06 79903-106 79903010606 40ab0cc1-c748-7bb4-e063-6294a90ab3c6 d91cc701-5e0a-d6c2-e053-2a95a90a9e75 |
Adverse event summaries are temporarily unavailable. Other product information remains available.